Shots: The sBLA approval is based on P-III immunogenicity and safety study assessing Fluzone High-Dose Quadrivalent vs two trivalent formulations of Fluzone High-Dose in 32,000 adults aged≥ 65yrs. over two influenza seasons […]readmore
Tags : High-Dose Quadrivalent